THCT · As filed with the SEC
THC Therapeutics balance sheet, by fiscal year
The statement as THC Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD
| USD | FY2024 Jul 31, 2024 | FY2023 Jul 31, 2023 | FY2022 Jul 31, 2022 | FY2021 Jul 31, 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash and Cash Equivalents | — | 10 | — | — |
| Cash | 35 | — | 32 | 296,130 |
| Prepaid Expenses | 0 | 970 | 40,656 | 4,586 |
| Inventory | — | 0 | 25 | 830 |
| Total current assets | 35 | 980 | 40,713 | 301,546 |
| Physical silver assets | — | — | — | 152,785 |
| Physical silver assets | — | — | 152,785 | — |
| Property, Plant and Equipment | — | — | 0 | 9,480 |
| Physical silver assets | — | 0 | — | — |
| Intangible Assets | — | 12,010 | 13,403 | 16,257 |
| Intangible Assets | 10,613 | — | — | — |
| Total assets | 10,648 | 12,990 | 206,901 | 480,068 |
| Current liabilities | ||||
| Accounts Payable | 1,319,294 | 1,936,637 | 1,580,689 | 485,010 |
| Accounts Payable | — | — | 16,807 | 513,512 |
| Advances from related parties | — | — | — | 96,313 |
| Accrued expenses - related party | — | 5,180 | — | — |
| Accounts payable and accrued liabilities - related party | 1,001,001 | — | — | — |
| Advances from related parties | 145,106 | 59,648 | 144,632 | — |
| Long-Term Debt | — | 25,000 | — | — |
| Short-Term Debt | — | 576,028 | — | 561,346 |
| Convertible Notes payable- Related party, net | — | — | — | 200,000 |
| Other Non-Operating Current Liabilities | — | — | — | 1,001,213 |
| Short-Term Debt | 25,000 | — | 25,000 | — |
| Short-Term Debt | 576,028 | — | 576,028 | — |
| Convertible notes payable- related party | — | — | 200,000 | — |
| Convertible notes payable, related party | 130,761 | 130,761 | — | — |
| Other Non-Operating Current Liabilities | 615,013 | 489,569 | 673,712 | — |
| Total current liabilities | 3,812,203 | 3,222,823 | 3,216,868 | 2,857,394 |
| Total liabilities | 3,812,203 | 3,222,823 | 3,216,868 | 2,857,394 |
| Commitments and Contingencies (See note 10) | 0 | 100,000 | 100,000 | 100,000 |
| Stockholders' deficit | ||||
| Preferred A Stock | — | — | — | 218 |
| Preferred B stock | — | — | — | 0 |
| Preferred C Stock | — | — | — | 0 |
| Series A Preferred Stock. | — | 226 | — | — |
| Series A Preferred Stock | 826 | — | 226 | — |
| Series B Preferred Stock | 0 | 0 | 0 | — |
| Series C Preferred Stock | 0 | 0 | 0 | — |
| Total Stockholders' Equity | 40,266 | 32,746 | 32,492 | 29,287 |
| Stock payable | — | 752,228 | 622,278 | 658,892 |
| Stock receivable | — | — | (6,902,000) | — |
| Stock receivable | — | (6,902,000) | — | (6,902,000) |
| Treasury stock | (97,500) | — | — | — |
| Stock payable | 486,228 | — | — | — |
| Stock receivable | (6,902,000) | — | — | — |
| Additional Paid-In Capital | 41,906,132 | 41,230,912 | 41,173,946 | 40,254,257 |
| Retained Earnings | (39,235,507) | (38,423,945) | (38,036,909) | (36,517,980) |
| Total stockholders' deficit | (3,801,555) | (3,309,833) | (3,109,967) | (2,477,326) |
| Total liabilities and stockholders' deficit | 10,648 | 12,990 | 206,901 | 480,068 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.